Page last updated: 2024-10-27

gabapentin and Autonomic Hyperreflexia

gabapentin has been researched along with Autonomic Hyperreflexia in 3 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Research Excerpts

ExcerptRelevanceReference
" We previously reported that once daily treatment with the anti-epileptic and neuropathic pain medication, gabapentin (GBP), at low dosage (50 mg/kg) mitigates experimentally induced AD soon after injections, likely by impeding glutamatergic signaling."5.56Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury. ( Cox, DH; Eldahan, KC; Gollihue, JL; Patel, SP; Rabchevsky, AG; Williams, HC, 2020)
"Behavioural assessments of tail muscle spasticity and mean arterial blood pressure responses to noxious somatic and/or visceral stimulation were used to test the effects of GBP on these abnormal reflexes."5.37Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury. ( Duale, H; Kitzman, PH; Lyttle, TS; O'Dell, CR; Patel, SP; Rabchevsky, AG, 2011)
" However, when mice are treated early after SCI with human-equivalent doses of the US Food and Drug Administration (FDA)-approved drug gabapentin (GBP), it is possible to block multi-segmental excitatory synaptogenesis and abolish sprouting of autonomic neurons that innervate immune organs and sensory afferents that trigger pain and autonomic dysreflexia (AD)."4.02Acute post-injury blockade of α2δ-1 calcium channel subunits prevents pathological autonomic plasticity after spinal cord injury. ( Brennan, FH; Davis, H; Eroglu, C; Ferguson, AR; Guan, Z; Harris, C; Mo, X; Noble, BT; Popovich, PG; Wang, Y, 2021)
" We previously reported that once daily treatment with the anti-epileptic and neuropathic pain medication, gabapentin (GBP), at low dosage (50 mg/kg) mitigates experimentally induced AD soon after injections, likely by impeding glutamatergic signaling."1.56Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury. ( Cox, DH; Eldahan, KC; Gollihue, JL; Patel, SP; Rabchevsky, AG; Williams, HC, 2020)
"Behavioural assessments of tail muscle spasticity and mean arterial blood pressure responses to noxious somatic and/or visceral stimulation were used to test the effects of GBP on these abnormal reflexes."1.37Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury. ( Duale, H; Kitzman, PH; Lyttle, TS; O'Dell, CR; Patel, SP; Rabchevsky, AG, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Eldahan, KC1
Williams, HC1
Cox, DH1
Gollihue, JL1
Patel, SP2
Rabchevsky, AG2
Brennan, FH1
Noble, BT1
Wang, Y1
Guan, Z1
Davis, H1
Mo, X1
Harris, C1
Eroglu, C1
Ferguson, AR1
Popovich, PG1
Duale, H1
Lyttle, TS1
O'Dell, CR1
Kitzman, PH1

Other Studies

3 other studies available for gabapentin and Autonomic Hyperreflexia

ArticleYear
Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury.
    Experimental neurology, 2020, Volume: 323

    Topics: Animals; Autonomic Dysreflexia; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists;

2020
Acute post-injury blockade of α2δ-1 calcium channel subunits prevents pathological autonomic plasticity after spinal cord injury.
    Cell reports, 2021, 01-26, Volume: 34, Issue:4

    Topics: Animals; Autonomic Dysreflexia; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Gabapen

2021
Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury.
    Spinal cord, 2011, Volume: 49, Issue:1

    Topics: Amines; Animals; Autonomic Dysreflexia; Cyclohexanecarboxylic Acids; Disease Models, Animal; Female;

2011